Oprozomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma: Initial Results from the Dose Escalation Portion of a Phase 1b/2, Multicenter, Open-Label StudyParameswaran Hari, Claudia Prada, Muneer H. Abidi et al.|Blood|2014Cited by 18
Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label StudyClaudia Prada, Parameswaran Hari, Kenneth H. Shain et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 5